National Resilience, Inc., a technology-focused biomanufacturing company, has announced William S. Marth as its new President and Chief Executive Officer, effective immediately. Mr. Marth transitions from his previous position as Resilience’s President and Chief Operating Officer, where he oversaw the
Resilience Government Services, a subsidiary of National Resilience, has secured approximately $17.5 million in funding to bolster domestic manufacturing of essential pharmaceutical components. The funding comes from the US Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness
National Resilience, the fast growing Contract Development and Manufacturing Organisation (CDMO), has announced investment in a modular facility design at their North Carolina, Research Triangle Park (RTP) biomanufacturing plant. This is the latest in a series of announcements from Resilience
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
